Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05100940 · ClinicalTrials.gov registry record

Progress Complication

A clinical trial of Coronary Artery Disease, sponsored by Minneapolis Heart Institute Foundation.

Recruiting
Registry status
4,000
Enrollment target
1
Study location

NCT05100940 is a study of Coronary Artery Disease that is actively recruiting participants, run by Minneapolis Heart Institute Foundation. The registered enrollment target is 4,000 participants, above the 1,269-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (215% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05100940, a study of Coronary Artery Disease, is actively recruiting participants, sponsored by Minneapolis Heart Institute Foundation.

RECRUITING
Registry status
4,000 participants
Enrollment target
1
Study location

Study Summary

Coronary angiography and percutaneous coronary intervention (PCI) is often performed in patients with ischemic heart disease. The safety of PCI has improved with new devices and strategies, but complications still occur, especially during complex procedures. The objectives of this multi-center observational registry are to examine frequency of complications occuring during cardiac catheterization and PCI, examine procedural strategies utilized for complication management, and evaluate the clinical outcomes (both immediate and during follow-up.)

Conditions Studied

Interventions

  • PROCEDURE Cardiac Catheterization

Study Locations (1)

Minnesota

  • Minneapolis Heart Institute Foundation - Minneapolis

Trial Details

FieldValue
Enrollment Target 4,000 participants
Start Date 2020-11-24
Est. Completion 2030-12-31

What the Registry Record Tells You About NCT05100940

The ClinicalTrials.gov registry entry for NCT05100940 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,269-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (215% higher). The listed sponsor is Minneapolis Heart Institute Foundation, which has 22 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Cardiac Catheterization is the first listed.

NCT05100940 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05100940 about?

NCT05100940 is a clinical study titled "Progress Complication". Coronary angiography and percutaneous coronary intervention (PCI) is often performed in patients with ischemic heart disease. The safety of PCI has improved with new devices and strategies, but complications still occur, especially during complex procedures. The objectives of this multi-center obser...

What is the current status of trial NCT05100940?

This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2020-11-24. Estimated completion is 2030-12-31.

What conditions does trial NCT05100940 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT05100940?

The interventions under investigation include: Cardiac Catheterization (PROCEDURE).

Who is sponsoring clinical trial NCT05100940?

This trial is sponsored by Minneapolis Heart Institute Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05100940 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.